Article
mRNA-based modalities for infectious disease management
6 Jul 2022
Abstract excerpt
The novel coronavirus disease 2019 (COVID-19) is still rampant all over the world, causing incalculable losses to the world. Major pharmaceutical organizations around the globe are focusing on vaccine research and drug development to prevent further damage caused by the pandemic. The messenger RNA (mRNA) technology has got ample of attention after the success of the two very effective mRNA vaccines during the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
